Search the Newsreel

Lithium Argentina AG (LAR.US) will release its earnings report before market open on August 11.

Lithium Argentina AG (LAR.US) is scheduled to release its earnings report before the market opens on August 11. Investors and analysts will be watching closely for the company's financial performance.

Gentex Corporation (GNTX) Stock Price, News, Quote & History

This page provides comprehensive financial information for Gentex Corporation (GNTX), an auto parts company specializing in digital vision, connected car, and dimmable glass technologies. It includes real-time stock price, historical data, key financial metrics, analyst ratings, and a company overview. The article highlights Gentex's …

Cogent Communications Holdings, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:CCOI) 2026-08-06

Cogent Communications Holdings, Inc. published its Q2 2026 earnings call presentation. The company reported an EPS of -$0.45, beating estimates by $0.50, and revenue of $235.56M, missing estimates by $4.23M with a 4.34% year-over-year decrease. The presentation was released in conjunction with their earnings …

Lithium Argentina Secures $220 Million Debt to Fund Cauchari-Olaroz Expansion

Lithium Argentina (TSE:LAR) has secured $220 million in new unsecured debt facilities to expand its Cauchari-Olaroz lithium brine operation in Argentina. This financing, backed by Ganfeng Lithium, will support a planned Stage 2 expansion to increase production by an additional 45,000 tonnes per year …

Cogent (CCOI) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended June 2026, Cogent Communications (CCOI) reported revenue of $235.56 million, down 4.3% over the same period last year. EPS came in at -$0.80, compared to -$1.21 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of …

Forgent Power Solutions (FPS) is Positioning for Long-Term Success through Innovation and Growth

Conestoga Capital Advisors, an asset management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. The letter reports a positive market shift towards Small Caps, with the Russell 2000 Index achieving its best first half since 1991 …

Is Cogent Communications (CCOI) a Value Play After Q2 Earnings M

CCC Intelligent Solutions Holdings (CCC) Performance Solid, But Prospective Returns Dwindle

Conestoga Capital Advisors, an asset management company, reported a positive shift towards Small Caps in its Q2 2026 investor letter. Despite a strong market for the Russell 2000 Growth Index, Conestoga's quality-focused strategies were impacted by uneven leadership, mirroring the Tech Bubble. The firm …

Cogent (NASDAQ:CCOI) Misses Q2 CY2026 Sales Expectations

Cogent (NASDAQ:CCOI) Misses Q2 CY2026 Sales Expectations Internet service provider Cogent Communications (NASDAQ:CCOI) fell short of the market's revenue expectations in Q2 CY2026, with sales falling 4.3% year on year to $235.6 million. Its GAAP profit of $1.38 per share was significantly above analysts' …

Cogent Communications (CCOI) Reports Q2 Loss, Misses Revenue Estimates

Cogent Communications (CCOI) came out with a quarterly loss of $0.8 per share versus the Zacks Consensus Estimate of a loss of $1.12. This compares to a loss of $1.21 per share a year ago. These figures are adjusted for non-recurring items. This quarterly …

Bank of America Corp DE Boosts Stake in Banco Bilbao Viscaya Argentaria S.A. $BBVA

Cogent Communications Q2 Adjusted Gross Profi

The article "Cogent Communications Q2 Adjusted Gross Profi" appears to be incomplete. It is likely a placeholder or an error in content retrieval, as only the title and the word "Document" are present.

Cogent Communications Reports Second Quarter 2026 Results

Cogent Communications Holdings, Inc. announced its Q2 2026 results, highlighting service revenue of $235.6 million. Key financial achievements include the sale of ten data centers for $224.2 million, resulting in a $130.7 million gain, and an EBITDA, as adjusted, of $71.1 million. The company …

Emergent BioSolutions Inc. 2026: Revenue $234.3M, EPS ($3.49) — 10-Q Summary

Emergent BioSolutions Inc. reported its second-quarter 2026 results, with revenue increasing to $234.3M from $140.9M year-over-year. Despite this growth, the company recorded a net loss of ($180.2M) and diluted EPS of ($3.49), primarily due to a $191M non-cash impairment on NARCAN® intangible assets. The …

Morgan Stanley Maintains VERSIGENT PLC(VGNT.US) With Buy Rating, Raises Target Price to $58

Morgan Stanley has reiterated its "Buy" rating on VERSIGENT PLC (VGNT.US) and increased its target price for the company's shares to $58. This indicates a continued positive outlook from the investment bank regarding VERSIGENT's future performance.

Versigent PLC Stock 12‑Month Price Target Raised to $55.9, Implies 22% Upside

Versigent PLC (VGNT) has seen its average 12-month price target increase to $55.9 from $55.2, with individual forecasts ranging from $52 to $60. This new target suggests a 22% potential upside based on the Aug. 4 closing price. The stock maintains a "Buy" consensus …

Cogent Communications (NASDAQ: CCOI) profit boosted by data center sale

Argent BioPharma (ASX:RGT): Why Does Cannepil Development Pathway Matter?

Versigent Ord Shs When Issued (VGNT) Earnings Forecast: Future EPS & Revenue Growth Estimates

Cogent Communications (CCOI) Earnings Date and Reports 2026

Loma Negra Compania Industrial Argentina (LOMA) Earnings Date and Reports 2026

Emergent BioSolutions (NYSE: EBS) posts Q2 loss, plans cost-cutting

Kaplan Fox Shareholder Alert: Deadline to Lead in the Securities Fraud Lawsuit Against Cogent Communications Holdings, Inc. (NASDAQ: CCOI) is September 21, 2026

Kaplan Fox & Kilsheimer LLP has filed a class action lawsuit against Cogent Communications Holdings, Inc. (NASDAQ: CCOI) on behalf of investors who purchased securities between February 29, 2024, and May 1, 2026. The lawsuit alleges that Cogent misrepresented the strength and growth of …

Argent BioPharma Advances CannEpil into U.S. Veterinary Market with New Development Program

Is Emergent BioSolutions Inc (EBS) Overvalued After Q2 Earnings

Emergent BioSolutions Inc. 2026 Q2 - Results - Earnings Call Presentation (NYSE:EBS) 2026-08-05

Key Points Interested in Emergent Biosolutions Inc.? Here are five stocks we like better. Q2 performance exceeded expectations: Revenue reached $234 million and adjusted EBITDA rose to $97 million, driven by accelerated medical countermeasure deliveries and strong U.S. government contract activity. NARCAN competition is …

Emergent BioSolutions Reports Second Quarter 2026 Financial Results

Emergent BioSolutions announced its second-quarter 2026 financial results, reporting total revenues of $234.3 million, a 66% increase year-over-year, and an adjusted net income of $30.9 million, up 134%. Despite a significant net loss due to a non-cash impairment charge, the company is implementing a …

COGENT CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Cogent Communications Holdings, Inc. and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Cogent (CCOI) To Contact Him Directly To Discuss Their Options If you purchased or acquired Cogent common stock between February 29, 2024 and May 1, 2026 and would like …

Narcan maker Emergent BioSolutions eliminates top R&D role in sweeping restructuring

Emergent BioSolutions is undergoing a significant restructuring, including laying off 93 employees, eliminating the chief medical officer and head of R&D role, and closing two labs. These changes, aimed at saving $40 million annually, are a response to increased competition in the naloxone market, …

Emergent records $191.3M non-cash charge related to NARCAN asset group

Emergent BioSolutions reported Q2 2026 total revenues of $234.3 million, a 66% increase year-over-year, driven primarily by higher U.S. government sales of smallpox and other medical countermeasure products. Despite this revenue growth and improved adjusted net income and EBITDA, the company posted a GAAP …

Emergent BioSolutions Commits to Cross-Sector Collaboration Against Biological Threats in an Evolving Global Security Environment

Emergent BioSolutions (NYSE: EBS) emphasizes the critical need for cross-sector collaboration to address evolving biological threats stemming from geopolitical conflicts, AI, and synthetic biology. The company highlights calls from European health officials and AI industry leaders for stronger safeguards and points to recent anthrax-related …

Telecom Argentina SA Class B Revenue Breakdown – BCBA:TECO2

Telecom Argentina SA Class B (BCBA:TECO2) generated 8.33 trillion ARS last year, with its Information and Communications Technology Services segment contributing 5.28 trillion ARS. The majority of the company's revenue, 8.03 trillion ARS, originated from Argentina.

Kessler Topaz Meltzer & Check, LLP Announces That a Securities Fraud Class Action Lawsuit Has Been Filed Against Cogent Communications Holdings, Inc.

Kessler Topaz Meltzer & Check, LLP has filed a securities fraud class action lawsuit against Cogent Communications Holdings, Inc. (NASDAQ: CCOI). The lawsuit, filed on behalf of investors who purchased Cogent common stock between February 29, 2024, and May 1, 2026, alleges material misstatements …

Intelligent Bio Solutions Completes Usability Study for Fingerprinting Drug Screen; 510(k) on Track

Intelligent Bio Solutions (INBS) has successfully completed a usability study for its Intelligent Fingerprinting Drug Screening System, demonstrating that non-specialist operators can accurately administer the system. This study, which involved 15 trained operators and followed FDA and ICH GCP standards, supports the company's 510(k) …

Intelligent Bio Solutions completes usability study for FDA filing

Intelligent Bio Solutions Inc. (NASDAQ:INBS) announced the successful completion of a usability study for its Intelligent Fingerprinting Drug Screening System. This study is a critical component of its FDA 510(k) submission for U.S. market clearance, specifically to detect the opiate codeine. The results demonstrated …

CCC Intelligent Solutions (NASDAQ: CCC) holder reports small Principal Global Investors stake

Principal Global Investors has reported a small stake in CCC Intelligent Solutions Holdings Inc. (NASDAQ: CCC) through a Schedule 13G/A filing. The firm beneficially owns 6,646 shares, representing 0% of the class, all with shared voting and dispositive power. This filing indicates that Principal …